Загрузка...
Gemfibrozil treatment: a comparison with clofibrate.
Gemfibrozil was found to be an effective hypotriglyceridaemic agent in types IV, IIb and V hyperlipoproteinaemia. When given at a dose level of 800 mg/day its activity was nearly of the same order of magnitude as 1.5 g/day of clofibrate.
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
1976
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1864044/ https://ncbi.nlm.nih.gov/pubmed/190609 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|